Product Information
QC MENSTRUAL PAIN RELIEF CAPLT is a generic product labeled by Chain Drug Marketing Association, priced at $0.0926 per EA under NDC 83324005720. Its NADAC has been published 96 times since Dec 4, 2024.
Strength
500; 25; 15 mg/1; mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324005720
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
6/21/2024
Price Statistics
The NADAC for QC MENSTRUAL PAIN RELIEF CAPLT has been published 96 times since Dec 4, 2024, and over the history we have for it it has risen 2.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0926 per EA |
|---|---|
| All-time high | $0.0926 (Sep 30, 2026) |
| All-time low | $0.0899 (May 21, 2025) |
| 52-week high | $0.0926 |
| 52-week low | $0.0905 |
| Median price | $0.0905 |
| Average price | $0.0908 |
| Largest weekly change | -1.6% (Apr 23, 2025) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen, Pamabrom, Pyrilamine Maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen, Pamabrom, Pyrilamine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC MENSTRUAL PAIN RELIEF CAPLT?
The current National Average Drug Acquisition Cost (NADAC) for QC MENSTRUAL PAIN RELIEF CAPLT, manufactured by Chain Drug Marketing Association, is $0.0926 per EA (NDC 83324005720), effective Sep 30, 2026.
How has the price of QC MENSTRUAL PAIN RELIEF CAPLT changed over time?
Over the history we have for it, the NADAC for QC MENSTRUAL PAIN RELIEF CAPLT has risen 2.3%. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC MENSTRUAL PAIN RELIEF CAPLT?
Since Dec 4, 2024, the NADAC for QC MENSTRUAL PAIN RELIEF CAPLT has ranged from a low of $0.0899 (May 21, 2025) to a high of $0.0926 (Sep 30, 2026), with a median of $0.0905 per EA.
Are there cheaper alternatives to QC MENSTRUAL PAIN RELIEF CAPLT?
No other NADAC-published product currently shares the active ingredient and strength of QC MENSTRUAL PAIN RELIEF CAPLT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC MENSTRUAL PAIN RELIEF CAPLT?
QC MENSTRUAL PAIN RELIEF CAPLT (NDC 83324005720) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.